Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 117, Issue 3, Pages 712-715Publisher
WILEY-BLACKWELL
DOI: 10.1046/j.1365-2141.2002.03430.x
Keywords
haemolytic anaemia; thrombocytopenia; mycophenolate mofetil; immunosuppression; auto-immunity
Categories
Ask authors/readers for more resources
The treatment of both auto-immune haemolytic anaemia (AIHA) and auto-immune thromobocytopenic purpura (AITP) remains unsatisfactory in those refractory to first-line management. Mycophenolate mofetil (MMF) is an immunosuppressive agent originally used to prevent acute rejection of solid organ transplants and used more recently in the management of auto-immune conditions. We report its use in four patients with AIHA and six patients with AITP. All four patients with AIHA and five of the six patients with AITP showed a complete or good partial response to treatment with MMF, confirming a possible role in the treatment of these conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available